Brief Mindfulness-Oriented Recovery Enhancement vs Brief Cognitive-Behavioral Therapy for Chronic Pain
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- The protocol lists: Brief Mindfulness Oriented Recovery Enhancement, Brief Cognitive-Behavioral Therapy.
- Who it may be relevant to
- Registry conditions: Chronic Pain. Basic parameters: from 18 years · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- United States
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Official title
Dual-Language Brief Mindfulness-Oriented Recovery Enhancement (B-MORE) vs Brief Cognitive-Behavioral Therapy (B-CBT) for Chronic Pain
Overview
This randomized controlled trial aims to test both English and Spanish versions of two, benign behavioral interventions for adults with chronic pain -- 1) Brief Mindfulness-Oriented Recovery Enhancement (B-MORE), and 2) Brief Cognitive- Behavioral Therapy (B-CBT).
Interventions
- Behavioral Brief Mindfulness Oriented Recovery Enhancement
B-MORE is a 2-hour adaptation of the traditional MORE program. - Behavioral Brief Cognitive-Behavioral Therapy
B-CBT is a 2-hour adaptation of a traditional 8-week CBT for Chronic Pain manual.
Primary outcome measures
- Program Feasibility [Time frame: At the first treatment session [1 hour] and the final treatment session [1 hour]]
- Treatment Acceptability [Time frame: Upon completion of the final treatment session [1 hour]]
Secondary outcome measures (5)
- Chronic Pain Symptoms [Time frame: Baseline and 2, 6, and 12-week post-treatment follow-ups]
- Depressive Symptoms [Time frame: Baseline and 2, 6, and 12-week post-treatment follow-ups]
- Anxiety Symptoms [Time frame: Baseline and 2, 6, and 12-week post-treatment follow-ups]
- Wellbeing [Time frame: Baseline and 2, 6, and 12-week post-treatment follow-ups]
- Pain Catastrophizing [Time frame: Baseline and 2, 6, and 12-week post-treatment follow-ups]
Eligibility criteria
Inclusion criteria
- Having a chronic pain condition
- Average pain of > 3 in the last week
- Willingness to engage with study assessments and interventions
- Understanding English or Spanish instructions fluently
- Age 18 and above.
Exclusion criteria
- Unable to consent because of physical or mental incapacity
- Have previous, formal mindfulness or CBT training (e.g., MBSR)
- Have pain from a current cancer diagnosis
- Unstable illness that may interfere with treatment
- Had surgery within the previous three months
- Had pain relieving injections, such as cortisone or hyaluronate, within the previous three months.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Healthy volunteers: No
Study design
- Allocation
- Randomized
- Model
- Parallel assignment
- Masking
- Single blind
- Primary purpose
- Treatment
Study locations
United States · 1 center
- Research Building B — Tallahassee
Identifiers
NCT: NCT07207174 · 00006512